AgeX Therapeutics (AGE) Institutional Ownership → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free AGE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisEarningsHeadlinesOwnershipSocial MediaStock AnalysisEarningsHeadlinesOwnershipSocial Media Institutional Ownership Changes (13F Filings) for AgeX Therapeutics (NYSE:AGE)CurrentInstitutional OwnershipPercentage12.50%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$42.99KNumber ofInstitutional Sellers(last 12 months)0 Get AGE Insider Trade Alerts Want to know when executives and insiders are buying or selling AgeX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AGE Institutional Buying and Selling by Quarter Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself AgeX Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/1/2024 Sigma Planning Corp286,425$110K0.0%+57.9%0.755% 11/6/2023 Sigma Planning Corp181,385$123K0.0%+29.8%0.478% 4/20/2023Strategic Wealth Investment Group LLC600$57K0.0%-99.3%0.002% 2/14/2023Susquehanna International Group LLP52,381$29K0.0%N/A0.138% 1/24/2023 Sigma Planning Corp134,977$74K0.0%+15.2%0.356% 10/21/2022Strategic Wealth Investment Group LLC82,010$46K0.0%-22.7%0.216% Get the Latest News and Ratings for AGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AgeX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022 Sigma Planning Corp116,650$67K0.0%+33.1%0.307% 1/21/2022Strategic Wealth Investment Group LLC112,251$122K0.0%+20.8%0.296% 10/28/2021 Sigma Planning Corp88,200$83K0.0%+70.6%0.232% 8/17/2021Bridgeway Capital Management LLC244,770$379K0.0%-19.7%0.645% 8/13/2021 Renaissance Technologies LLC75,059$116K0.0%-77.3%0.198% 8/13/2021 Sigma Planning Corp51,700$80K0.0%+120.0%0.136% 5/18/2021Millennium Management LLC18,523$30K0.0%-82.3%0.049% 5/13/2021 Renaissance Technologies LLC330,500$535K0.0%+212.7%0.871% 2/10/2021 Renaissance Technologies LLC105,700$161K0.0%N/A0.280% 11/3/2020Strategic Wealth Designers57,325$46K0.0%+21.6%0.152% 10/23/2020 Defender Capital LLC.35,597$29K0.0%-17.4%0.094% 10/20/2020Wedbush Securities Inc.67,927$55K0.0%N/A0.180% 8/31/2020Bridgeway Capital Management Inc.154,770$147K0.0%N/A0.411% 8/14/2020Bank of America Corp DE152,838$144K0.0%+8,238.1%0.406% 7/13/2020Strategic Wealth Designers47,157$45K0.0%N/A0.125% 6/19/2020State Street Corp293,888$273K0.0%+11.8%0.780% 5/14/2020 Wells Fargo & Company MN44,474$41K0.0%+630.2%0.118% 5/14/2020 Defender Capital LLC.50,997$47K0.0%-63.1%0.135% 5/11/2020State Street Corp293,888$273K0.0%+11.8%0.780% 5/1/2020 BlackRock Inc.1,143,580$1.06M0.0%-2.2%3.037% (Data available from 1/1/2016 forward) AGE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AGE shares? During the previous two years, the following institutional investors and hedge funds held shares of AgeX Therapeutics shares: Sigma Planning Corp ($110K), and Strategic Wealth Investment Group LLC ($57K), Susquehanna International Group LLP ($29K).Learn more on AGE's institutional investors. What percentage of AgeX Therapeutics stock is owned by institutional investors? 12.50% of AgeX Therapeutics stock is owned by institutional investors. Learn more on AGE's institutional investor holdings. Which institutional investors have been buying AgeX Therapeutics stock? The following institutional investors have purchased AgeX Therapeutics stock in the last 24 months: Sigma Planning Corp ($193.50K), and Susquehanna International Group LLP ($52.38K). How much institutional buying is happening at AgeX Therapeutics? Institutional investors have bought a total of 245,883 shares in the last 24 months. This purchase volume represents approximately $77.64K in transactions. Which AgeX Therapeutics major shareholders have been selling company stock? The following institutional investors have sold AgeX Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($109.87K). How much institutional selling is happening at AgeX Therapeutics? Institutional investors have sold a total of 109,868 shares in the last 24 months. This volume of shares sold represents approximately $44.00K in transactions. Related Companies: ELAB Major Shareholders AKTX Major Shareholders MBRX Major Shareholders MIRA Major Shareholders ABVC Major Shareholders PPBT Major Shareholders KPRX Major Shareholders ERNA Major Shareholders MNPR Major Shareholders MTEM Major Shareholders This page (NYSE:AGE) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBill Clinton Backing Biden Replacement???The Freeport SocietyTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow to Play the AI and Crypto Markets in One SwingWeiss Ratingsis this a buy and hold stock?Tips4Traders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AgeX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
